RIAS
ADPT icon

Rachor Investment Advisory Services’s Adaptive Biotechnologies ADPT Stock Holding History

Rachor Investment Advisory Services’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-7
Closed -$98 – 209
2026
Q1 		$98 Hold
7
– – ﹤0.01% 454
2025
Q4 		$114 Buy
+7
New +$114 ﹤0.01% 413

Other funds holding ADPT

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
AWM
Affinity Wealth Management Wilmington, Delaware $776M AUM 43.59% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.21B AUM 82.36% 1-Year Est. Return

Rachor Investment Advisory Services's ADPT Position: Q2 2026 in Review

Rachor Investment Advisory Services sold out of Adaptive Biotechnologies (ADPT) in Q2 2026, closing a stake of 7 shares — an estimated $98 sold.

Rachor Investment Advisory Services first reported a position in ADPT in Q4 2025 and held it in 2 quarters. The position peaked at $114 in Q4 2025. 104 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Rachor Investment Advisory Services reported no remaining Adaptive Biotechnologies position as of Q2 2026 after selling out during the quarter.
  • Rachor Investment Advisory Services sold 7 Adaptive Biotechnologies shares in Q2 2026, an estimated $98.
  • Rachor Investment Advisory Services first reported a position in Adaptive Biotechnologies in Q4 2025 and held it in 2 quarters.
  • Rachor Investment Advisory Services's Adaptive Biotechnologies position peaked at $114 in Q4 2025.
  • 104 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Rachor Investment Advisory Services's 13F filing for Q2 2026, filed 16 Jul 2026.